Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia by Alfonso Quintás-Cardama, Farhad Ravandi, Theresa Liu-Dumlao, Mark Brandt, Stefan Faderl, Sherry Pierce, Gautam Borthakur, Guillermo Garcia-Manero, Jorge Cortes, and Hagop Kantarjian Blood Volume 120(24): December 6, 2012 ©2012 by American Society of Hematology
Survival times of patients treated with standard intensive AML chemotherapy. Alfonso Quintás-Cardama et al. Blood 2012;120: ©2012 by American Society of Hematology
OS of patients treated with epigenetic therapy compared with patients treated with AI or other high-dose ara-C–containing regimens. Alfonso Quintás-Cardama et al. Blood 2012;120: ©2012 by American Society of Hematology